Rwanda's Pension Fund Focuses on Pharmaceutical Innovations
Thursday, 17 October 2024, 08:59
Rwanda's Strategic Investment in Pharmaceuticals
In a significant move, Rwanda is making its third bid to enhance the pharmaceutical landscape through its pension fund. The Rwanda Social Security Board (RSSB) is at the forefront of this initiative, partnering with Akagera Medicines Africa and the European Investment Bank (EIB).
Collaborative Efforts for Vaccine Development
- Commercial financing is essential for advancing pharmaceutical innovations.
- Efforts are directed towards critical health challenges, including HIV and Lassa fever.
- This aligns with the Global Gateway Initiative, ensuring comprehensive investment strategies.
The collaboration signifies a push towards sustainable investment that not only benefits the healthcare system but also enhances Rwanda's economic standing.
This article was prepared using information from open sources in accordance with the principles of Ethical Policy. The editorial team is not responsible for absolute accuracy, as it relies on data from the sources referenced.